Safety and Effectiveness Evaluation of the Apotech® Diabetic Body Moisturizer

Safety and Effectiveness Evaluation of a New Moisturizer Formulation With Antioxidant, Anti-inflammatory and Anti-microbial Effects in the Prevention of a Diabetic Skin Dryness and Complications

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT03192592

Acronym

Apotech

Enrollment

Registered

2017-06-20

Start date

2017-05-02

Completion date

2017-07-28

Last updated

2017-06-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Skin Care, Skin Diseases, Metabolic

Brief summary

Safety and effectiveness evaluation of a new moisturizer formulation with antioxidant, anti-inflammatory and anti-microbial effects in the prevention of diabetics dry skin and complications.

Detailed description

Safety and effectiveness evaluation of a new moisturizer formulation with antioxidant, anti-inflammatory and anti-microbial effects in the prevention of diabetics dry skin and complications. This study aim to address the target population, subjects with controlled diabetes, to verify the improvement of texture, elasticity, and general appearance of the skin through the application of the cosmetic product Apotech®.

Interventions

OTHERBody moisturizer

Daily body moisturizer application for skin protection and barrier.

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

PREVENTION

Masking

NONE

Intervention model description

This study aim to verify the improvement of texture, elasticity and general appearance of the skin through the application of the cosmetic product Apotech®.

Eligibility

Sex/Gender

ALL

Age

18 Years to 70 Years

Healthy volunteers

Inclusion criteria

* Subjects with controlled diabetes * Any phototype and all skin types

Exclusion criteria

* Pregnant women * Subjects that not match the inclusion criteria

Design outcomes

Primary

Measure	Time frame	Description
Skin general appearance	28 days	Standard guide for sensory claim substantiation - ASTM
Skin texture	28 days	Standard guide for sensory claim substantiation - ASTM
Skin hydration	28 days	Standard guide for sensory claim substantiation - ASTM
Skin elasticity and visible cracking	28 days	Standard guide for sensory claim substantiation - ASTM

Secondary

Measure	Time frame	Description
Sensory evaluation of the product	28 days	Standard questions

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026